Free radicals as triggers of brain edema formation after stroke.

Brain edema is a leading cause of death after stroke. Cytotoxic edema, which is most severe in astrocytes, begins within a few minutes of adenosine triphosphate depletion and reflects the ultimate infarct size. Vasogenic edema is caused by uncontrolled fluid leakage from the blood to the brain parenchyma through a weakened blood-brain barrier (BBB) and contributes to an actual net volume increase of the brain, which often leads to death. Recent research on ischemia-induced injury mechanisms of the microvasculature has led to the disclosure of the mechanisms and cellular pathways leading to BBB breakdown. In addition, the introduction of magnetic resonance imaging to clinical practice has enabled the evaluation of edema severity in stroke patients and differentiation between cytotoxic and vasogenic edema. Free radicals exert their deleterious actions during both cytotoxic and vasogenic edema. They can contribute to BBB disruption directly and can also trigger molecular pathways related to the dysfunction of ion transporters in the cell membrane and those related to increased vascular permeability. The development of effective therapeutic strategies aimed at reducing brain edema based on targeting specific molecular pathways involved may reduce death and disability from stroke.

[1]  D. Corbett,et al.  Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke , 2001, Neuropharmacology.

[2]  S. Ibayashi,et al.  Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion , 2004, Journal of the Neurological Sciences.

[3]  J. Koziol,et al.  Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Carol Cass,et al.  Nitric Oxide and Cyclic GMP Increase the Expression of Matrix Metalloproteinase-9 in Vascular Smooth Muscle , 2003, Journal of Pharmacology and Experimental Therapeutics.

[5]  F. Barone,et al.  Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. , 1998, Stroke.

[6]  Kyung-Yul Lee,et al.  Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure , 2003, Stroke.

[7]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[8]  P. Bracci,et al.  Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia , 2004, Stroke.

[9]  V. Vallyathan,et al.  Hydroxyl radical formation is greater in striatal core than in penumbra in a rat model of ischemic stroke , 2003, Journal of neuroscience research.

[10]  R. Borchardt,et al.  VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. , 2001, American journal of physiology. Heart and circulatory physiology.

[11]  M. Schroeter,et al.  Astrocytes enhance radical defence in capillary endothelial cells constituting the blood‐brain barrier , 1999, FEBS letters.

[12]  N. Plesnila,et al.  Contribution of Anion Transporters to the Acidosis‐Induced Swelling and Intracellular Acidification of Glial Cells , 2000, Journal of neurochemistry.

[13]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[14]  N. van Bruggen,et al.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.

[15]  C. Cierniewski,et al.  Dual regulatory effects of nitric oxide on plasminogen activator inhibitor type 1 expression in endothelial cells. , 2000, European journal of biochemistry.

[16]  K. Scharffetter-Kochanek,et al.  Stable Overexpression of Manganese Superoxide Dismutase in Mitochondria Identifies Hydrogen Peroxide as a Major Oxidant in the AP-1-mediated Induction of Matrix-degrading Metalloprotease-1* , 1999, The Journal of Biological Chemistry.

[17]  J. Bodmer,et al.  Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. , 1996, The Journal of clinical investigation.

[18]  M. Goldberg,et al.  AMPA/Kainate Receptor Activation Mediates Hypoxic Oligodendrocyte Death and Axonal Injury in Cerebral White Matter , 2001, The Journal of Neuroscience.

[19]  K. Welch,et al.  Acute tissue response to cerebral ischemia in the gerbil An ultrastructural study , 1977, Journal of the Neurological Sciences.

[20]  M. Kornfeld,et al.  Collagenase-induced intracerebral hemorrhage in rats. , 1990, Stroke.

[21]  P. Chan,et al.  The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood–brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice , 2001, Neuroscience.

[22]  M. Marikovsky,et al.  Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response1 , 2003, The Journal of Immunology.

[23]  T. Omae,et al.  Separating changes in the intra‐ and extracellular water apparent diffusion coefficient following focal cerebral ischemia in the rat brain , 2002, Magnetic resonance in medicine.

[24]  G. Schmid-Schönbein,et al.  Polymorphonuclear Leukocytes Occlude Capillaries Following Middle Cerebral Artery Occlusion and Reperfusion in Baboons , 1991, Stroke.

[25]  C. Granziera,et al.  Astrocyte-Specific Expression of Aquaporin-9 in Mouse Brain is Increased after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  J. Arenillas,et al.  Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke , 2003, Circulation.

[27]  T. Kent,et al.  Superoxide anion production during reperfusion is reduced by an antineutrophil antibody after prolonged cerebral ischemia. , 1999, Free radical biology & medicine.

[28]  P. Chan,et al.  Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals , 1984, Neurology.

[29]  P. Sandercock,et al.  Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.

[30]  G. Rosenberg,et al.  Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion , 2003, Stroke.

[31]  T. Hinds,et al.  Inhibition of Ca2+-pump ATPase and the Na+/K+-pump ATPase by iron-generated free radicals. Protection by 6,7-dimethyl-2,4-DI-1- pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger. , 1996, Biochemical pharmacology.

[32]  G. Rosenberg,et al.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.

[33]  W. Hacke,et al.  'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs , 1996 .

[34]  H. Weiss,et al.  Effects of cyclic GMP on microvascular permeability of the cerebral cortex. , 1999, Microvascular research.

[35]  G. Hamann,et al.  Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. , 1995, Stroke.

[36]  J. Garcìa,et al.  Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. , 1995, Stroke.

[37]  I. Romero,et al.  Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. , 1999, Free radical biology & medicine.

[38]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[39]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[40]  T. Kietzmann,et al.  Enhanced plasminogen activator inhibitor-1 expression in transgenic mice with hepatocyte-specific overexpression of superoxide dismutase or glutathione peroxidase. , 2004, Antioxidants & redox signaling.

[41]  Ching‐Jen Wang,et al.  Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1α and VEGF-A Expression in Shock Wave-stimulated Osteoblasts* , 2004, Journal of Biological Chemistry.

[42]  J. Garcìa,et al.  Cerebral white matter is highly vulnerable to ischemia. , 1996, Stroke.

[43]  T. Nagafuji,et al.  Blockade of nitric oxide formation by Nω-nitro-l-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats , 1992, Neuroscience Letters.

[44]  D. DeLong,et al.  Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction , 2003, Cerebrovascular Diseases.

[45]  Cornelius Weiller,et al.  Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion-Weighted Magnetic Resonance Imaging , 2003, Stroke.

[46]  I. Klatzo Evolution of brain edema concepts. , 1994, Acta neurochirurgica. Supplementum.

[47]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[48]  D. Lumenta,et al.  Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia , 2002, Brain Research.

[49]  H. Oh,et al.  Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. , 2004, Life sciences.

[50]  Hall Ed,et al.  Involvement of lipid peroxidation in CNS injury. , 1992 .

[51]  Turgay Dalkara,et al.  Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia , 2004, Stroke.

[52]  C. Iadecola,et al.  Time Dependence of Effect of Nitric Oxide Synthase Inhibition on Cerebral Ischemic Damage , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  K. Kugiyama,et al.  Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[54]  L. Iversen,et al.  Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability , 2001, Nature Medicine.

[55]  D. Choi,et al.  Brain tissue responses to ischemia. , 2000, The Journal of clinical investigation.

[56]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[57]  Ole P. Ottersen,et al.  The molecular basis of water transport in the brain , 2003, Nature Reviews Neuroscience.

[58]  G. Manley,et al.  Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke , 2000, Nature Medicine.

[59]  S. Holland,et al.  The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. , 2002, Free radical biology & medicine.

[60]  U. Ito,et al.  CT enhancement after prolonged high-dose contrast infusion in the early stage of cerebral infarction. , 1986, Stroke.

[61]  L. Hertz,et al.  Peroxide‐scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress , 1998, Glia.

[62]  B. Risberg,et al.  Reactive oxygen intermediates and ischemia-reperfusion injury release tissue plasminogen activator from isolated rat hearts. , 1993, Thrombosis research.

[63]  A. Mazar,et al.  Activation Systems for Latent Matrix Metalloproteinase-2 are Upregulated Immediately after Focal Cerebral Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  W. Heiss,et al.  Extracellular Concentrations of Non–Transmitter Amino Acids in Peri-Infarct Tissue of Patients Predict Malignant Middle Cerebral Artery Infarction , 2003, Stroke.

[65]  E. Lo,et al.  Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[66]  A. Betz Identification of Hypoxanthine Transport and Xanthine Oxidase Activity in Brain Capillaries , 1985, Journal of neurochemistry.

[67]  R. V. Sharma,et al.  Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. , 2001, American journal of physiology. Heart and circulatory physiology.

[68]  H. Duan,et al.  v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. , 2001, Free radical biology & medicine.

[69]  M. Rice,et al.  Differential compartmentalization of brain ascorbate and glutathione between neurons and glia , 1997, Neuroscience.

[70]  U. Förstermann,et al.  Nitric Oxide Increases the Decay of Matrix Metalloproteinase 9 mRNA by Inhibiting the Expression of mRNA-Stabilizing Factor HuR , 2003, Molecular and Cellular Biology.

[71]  R. Regan,et al.  Hemin induces an iron‐dependent, oxidative injury to human neuron‐like cells , 2003, Journal of neuroscience research.

[72]  J. Koziol,et al.  Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion , 2001, Stroke.

[73]  O. Kempski,et al.  Neuron-glial interaction during injury and edema of the CNS. , 1994, Acta neurochirurgica. Supplementum.

[74]  M. Fujimura,et al.  Early appearance of activated matrix metalloproteinase-9 and blood–brain barrier disruption in mice after focal cerebral ischemia and reperfusion , 1999, Brain Research.

[75]  G. D. del Zoppo,et al.  Rapid Loss of Microvascular Integrin Expression during Focal Brain Ischemia Reflects Neuron Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[76]  J. Tsuruda,et al.  Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. , 1990, Radiology.

[77]  J. Cervós-Navarro,et al.  Morphological changes in acute cerebral ischemia after occlusion and reperfusion in the rat. , 1990, Advances in neurology.

[78]  S. Warach,et al.  Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy: The NINDS Suburban Hospital Stroke Center Experience , 2003, Stroke.

[79]  D. Collen,et al.  Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture. , 1990, The Journal of biological chemistry.

[80]  J. Garcìa,et al.  Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). , 1994, The American journal of pathology.

[81]  J. Koziol,et al.  Activated Microvessels Express Vascular Endothelial Growth Factor and Integrin αvβ3 During Focal Cerebral Ischemia , 1999 .

[82]  B. Siesjö,et al.  Molecular mechanisms of acidosis-mediated damage. , 1996, Acta neurochirurgica. Supplement.

[83]  E. Haley High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS II Investigators. , 1998, Stroke.

[84]  T. Davis,et al.  Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke , 2002, Stroke.

[85]  D. Ray,et al.  Reversible disruption of tight junction complexes in the rat blood‐brain barrier, following transitory focal astrocyte loss , 2004, Glia.

[86]  O. Wu,et al.  Delayed rt-PA Treatment in a Rat Embolic Stroke Model: Diagnosis and Prognosis of Ischemic Injury and Hemorrhagic Transformation with Magnetic Resonance Imaging , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[87]  R. Caldwell,et al.  Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. , 2003, The American journal of pathology.

[88]  Jieli Chen,et al.  Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat , 2003, Circulation research.

[89]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[90]  W. Armstead,et al.  Polyethylene Glycol Superoxide Dismutase and Catalase Attenuate Increased Blood–Brain Barrier Permeability After Ischemia in Piglets , 1992, Stroke.

[91]  J. Kourie,et al.  Interaction of reactive oxygen species with ion transport mechanisms. , 1998, American journal of physiology. Cell physiology.

[92]  G. Rosenberg,et al.  Xanthine oxidase activates pro-matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells through non-free radical mechanisms. , 2004, Archives of biochemistry and biophysics.

[93]  H. Harper,et al.  Clustering of Urokinase Receptors (uPAR; CD87) Induces Proinflammatory Signaling in Human Polymorphonuclear Neutrophils1 , 2000, The Journal of Immunology.

[94]  Elisabetta Dejana,et al.  Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.